Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Membership Matters

Alternative delivery model for estates and facilities

You may have read in the news that the Trust’s Board of Directors has approved the establishment of an alternative delivery model for estates and facilities, which will remain wholly owned by the NHS.

At their meeting on 28 February, the Board considered the models available and agreed to set up a Limited Liability Partnership with Northumbria Healthcare Facilities Management Limited as a minority partner.  Northumbria established its alternative delivery model in 2012 and has a strong track record of working in this way.  Their expertise will be extremely valuable throughout this process and it will prove beneficial to share their experience.

The company has now been formally registered, and the plan is that it will become operational from October 2018.

The company name will be York Teaching Hospital Facilities Management to mirror the name of the Trust and to underline the importance of keeping estates and facilities staff as part of the NHS and part of the Trust family.

York Teaching Hospital Facilities Management will remain wholly owned by the NHS and any staff moving to the new organisation will be able to keep their current NHS Agenda for Change terms and conditions.

Internal hospital signage with arrows to Main Reception, Outpatients and Pharmacy

A-Z of Services

Two female receptionists on the phone at a desk smiling

Feedback

Chinese Poland

View all languages >

Visiting update

To protect our patients, staff, visitors and the community, we are again restricting visitors to all our hospitals sites so please read our latest guidance for full details before coming to our hospitals.

The decision to restrict visitors during this time has been very difficult and made only after careful consideration as we witness wider social restrictions to prevent the spread of COVID-19 in light of the highly transmissible OMICRON variant.  The guidance will be reviewed regularly.